{"id":21945,"date":"2016-02-15T18:55:39","date_gmt":"2016-02-15T16:55:39","guid":{"rendered":"http:\/\/infois.ro\/?p=21945"},"modified":"2016-02-16T09:02:46","modified_gmt":"2016-02-16T07:02:46","slug":"antibiotice-sa-iasi-si-a-indeplinit-tintele-stabilite-pentru-anul-2015","status":"publish","type":"post","link":"http:\/\/infois.ro\/?p=21945","title":{"rendered":"Antibiotice SA Ia\u015fi \u015fi-a \u00eendeplinit \u0163intele stabilite pentru anul 2015"},"content":{"rendered":"<p style=\"text-align: justify;\"><a href=\"http:\/\/infois.ro\/wp-content\/uploads\/2014\/11\/antibiotice.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft  wp-image-14461\" src=\"http:\/\/infois.ro\/wp-content\/uploads\/2014\/11\/antibiotice.jpg\" alt=\"antibiotice\" width=\"310\" height=\"463\" srcset=\"http:\/\/infois.ro\/wp-content\/uploads\/2014\/11\/antibiotice.jpg 600w, http:\/\/infois.ro\/wp-content\/uploads\/2014\/11\/antibiotice-200x300.jpg 200w\" sizes=\"(max-width: 310px) 100vw, 310px\" \/><\/a><\/p>\n<p style=\"text-align: justify;\">Ast\u0103zi, 15 februarie 2016, compania Antibiotice SA (simbol ATB) a remis Bursei de Valori Bucure\u015fti raportul cuprinz\u00e2nd rezultatele economico-financiare anuale preliminate 2015 care confirm\u0103 politica de consolidare adoptat\u0103 de companie \u00een ultimii ani.<\/p>\n<p style=\"text-align: justify;\"><strong>Antibiotice &#8211; cre\u015fteri peste nivelul pie\u0163ei farmaceutice rom\u00e2ne\u015fti<\/strong><\/p>\n<p style=\"text-align: justify;\">De\u015fi pia\u0163a total\u0103 a \u00eenregistrat \u00een 2015 pentru prima dat\u0103 \u00een ultimii ani o sc\u0103dere (ie\u015firi din farmacii \u015fi spitale) at\u00e2t la nivel valoric c\u00e2t \u015fi cantitativ, Antibiotice SA a reu\u015fit s\u0103 ob\u0163in\u0103 cea mai important\u0103 cre\u015ftere din top 15 companii:<\/p>\n<ul style=\"text-align: justify;\">\n<li>+11,62% din punct de vedere valoric (comparativ cu sc\u0103derea \u00eenregistrat\u0103 de pia\u0163a total\u0103 de -4.74%), ocup\u00e2nd locul 13 \u00een pia\u0163a total\u0103 cu o cot\u0103 de pia\u0163\u0103 de 2,45%,<\/li>\n<li>+2,1% din punct de vedere cantitativ (comparativ cu sc\u0103derea \u00een consum \u00eenregistrat\u0103 de pia\u0163a total\u0103 de -0.87%), ocup\u00e2nd locul 4 \u00een topul companiilor prezente pe pia\u0163a genericelor \u015fi OTC+lor din Rom\u00e2nia \u00een urcare o pozi\u0163ie comparativ cu 2014. Totodat\u0103, Antibiotice furnizeaz\u0103 5,56% din volumele pie\u0163ei totale.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">Ca \u015fi pondere \u00een structura v\u00e2nz\u0103rilor Antibiotice, segmentul de retail (v\u00e2nz\u0103ri \u00een farmacii) reprezint\u0103 principalul canal de v\u00e2nzare (75% valoric). Astfel, \u00een anul 2015, segmentul de retail a \u00eenregistrat o evolu\u0163ie pozitiv\u0103 la nivel valoric (<strong>+10,81%)<\/strong> comparativ cu sc\u0103derea \u00eenregistrat\u0103 de pia\u0163\u0103 de (-5,73%).<\/p>\n<p style=\"text-align: justify;\">Cre\u015fterea valoric\u0103 pe pia\u0163a de retail a fost posibil\u0103 \u00een principal datorit\u0103 evolu\u0163iei superioare a v\u00e2nz\u0103rilor de medicamente din urm\u0103toarele clasele terapeutice, care au generat cre\u015fteri de peste 10% fiecare:<\/p>\n<ul style=\"text-align: justify;\">\n<li><em>Antiinfec\u0163ioase de Uz Sistemic<\/em> (cre\u015ftere de +10,13 %);<\/li>\n<li><em>Preparate dermatologice<\/em> (cre\u015ftere de +16,60 %);<\/li>\n<li><em>Tract digestiv<\/em> (cre\u015ftere de +14,44%);<\/li>\n<li><em>Sistem Cardiovascular<\/em> (cre\u015ftere de +11,04%).<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">V\u00e2nz\u0103rile cantitative ale companiei Antibiotice pe segmentul de retail au crescut, peste nivelul pie\u0163ei cu <strong>+3,43%<\/strong> (comparativ cu sc\u0103derea \u00eenregistrat\u0103 de pia\u0163\u0103 -0,98%).<\/p>\n<p style=\"text-align: justify;\">\u00cen ceea ce prive\u015fte canalul de v\u00e2nzare hospital medicamentele marca Antibiotice \u00eenregistreaz\u0103 \u00een anul 2015 comparativ cu 2014 o cre\u015ftere valoric\u0103 de <strong>+14,11%<\/strong> comparativ cu cre\u015fterea de +2,72% \u00eenregistrat\u0103 de pia\u0163\u0103. Cre\u015fterea valoric\u0103 pe pia\u0163a de hospital (generice \u015fi OTC) a fost influen\u0163at\u0103 \u00een special de evolu\u0163ia pozitiv\u0103 a v\u00e2nz\u0103rilor medicamentelor antiinfec\u0163ioase (+16,10%).<\/p>\n<p style=\"text-align: justify;\">Cu o cot\u0103 de pia\u0163\u0103 de 18,8% (\u00een cre\u015ftere cu <strong>10,6%<\/strong> comparativ cu 2014), <strong>Antibiotice este lider pe pia\u0163a genericelor <\/strong>\u015fi<strong> OTC-urilor v\u00e2ndute \u00een spitalele din Rom\u00e2nia.<\/strong><\/p>\n<p style=\"text-align: justify;\">\u00cen 2015 portofoliul companiei a fost completat cu 5 produse noi din clasele terapeutice pe care Antibiotice dore\u015fte s\u0103-\u015fi consolideze pozi\u0163ia \u00een urm\u0103torii ani: clasa Antiinfec\u0163ioase, clasa Preparate dermatologice \u015fi clasa Genito-Urinar.<\/p>\n<p style=\"text-align: justify;\"><strong>Continuitate \u00een pozi\u0163ii de top<\/strong><\/p>\n<p style=\"text-align: justify;\">\u00cen 2015 au fost identificate strategiile optime de consolidare care au permis societ\u0103\u0163ii consolidarea pe segmente de pia\u0163\u0103 unde e recunoscut\u0103:<\/p>\n<ul style=\"text-align: justify;\">\n<li>locul 1 pe segmentul de unguente &#8211; cot\u0103 de pia\u0163\u0103 27,7%;<\/li>\n<li>locul 1 pe segmentul supozitoare &#8211; cot\u0103 de pia\u0163\u0103 42,44%;<\/li>\n<li>locul 1 pe segmentul pulberi injectabile &#8211; cot\u0103 de pia\u0163\u0103 75,38%.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><em>\u201e\u00cen condi\u0163iile \u00een care pre\u0163urile medicamentelor generice s-au redus \u00een medie cu 20% de la inceputul lunii iulie 2015, iar taxa clawback la Antibiotice a reprezentat 11,1% din veniturile de produse ob\u0163inute pe pia\u0163a intern\u0103, <strong>societatea \u015fi-a \u00eendeplinit indicatorii bugeta\u0163i. <\/strong>Astfel, am reu\u015fit s\u0103 cre\u015ftem veniturile din v\u00e2nz\u0103ri (ie\u015firi din ATB<\/em><em>)<\/em><em> cu un procent comparativ cu cifrele bugetate \u015fi s\u0103 aplic\u0103m o politic\u0103 pruden\u0163ial\u0103 \u00een ceea ce prive\u015fte ajust\u0103rile la nivelul clien\u0163ilor pie\u0163ei de retail, de aproximativ 5000 de farmacii. Neefectuarea acestor ajust\u0103ri ar fi dus profitul brut la nivelul de 42 milioane lei\u201d, a declarat Ioan Nani, director general Antibiotice.<\/em><\/p>\n<p style=\"text-align: justify;\">Obiectivele anului 2015 au avut \u00een vedere realizarea bugetului aprobat de Consiliul de Administra\u0163ie \u015fi Adunarea General\u0103 a Ac\u0163ionarilor, astfel:<\/p>\n<table>\n<tbody>\n<tr>\n<td width=\"158\">Indicator<\/td>\n<td width=\"96\">Realizat<\/td>\n<td width=\"96\">Bugetat<\/td>\n<td width=\"56\">Indice<\/td>\n<\/tr>\n<tr>\n<td width=\"158\"><strong>Venituri din v\u00e2nz\u0103ri<\/strong><\/td>\n<td width=\"96\">330,087,508<\/td>\n<td width=\"96\">326,148,000<\/td>\n<td width=\"56\"><strong>1.01<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"158\"><strong>Profit brut<\/strong><\/td>\n<td width=\"96\">32,047,535<\/td>\n<td width=\"96\">26,112,000<\/td>\n<td width=\"56\"><strong>1.23<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"text-align: justify;\">\nDe asemenea, s-a avut \u00een vedere destocarea farmaciilor \u015fi a canalele de v\u00e2nzare (distribu\u0163ie, hospital, retail).<\/p>\n<p style=\"text-align: justify;\"><strong>Avans de 7% pe pie\u0163ele externe<\/strong><\/p>\n<p style=\"text-align: justify;\">Antibiotice a \u00eencheiat anul 2015 cu o cifr\u0103 de afaceri la export de 20,5 milioane euro, \u00een cre\u015ftere cu 7% fa\u0163\u0103 de anul 2014. Totodat\u0103, profitul din v\u00e2nz\u0103rile la export a crescut cu 45% comparativ cu anul anterior. Cre\u015fterea a fost determinat\u0103 \u00een principal de evolu\u0163ia pozitiv\u0103 a v\u00e2nz\u0103rilor de Nistatin\u0103 substan\u0163\u0103 activ\u0103, produs pentru care Antibiotice \u00ee\u015fi men\u0163ine de 3 ani pozi\u0163ia de lider mondial.<\/p>\n<p style=\"text-align: justify;\">Pentru produsele finite, principala pia\u0163\u0103 de desfacere \u00een anul 2015 a fost America de Nord, \u00een principal prin exporturile de produse injectabile pe pia\u0163a S.U.A., Antibiotice av\u00e2nd \u00eenregistrate 6 produse \u00een aceasta pia\u0163\u0103. De asemenea, produsele finite marca Antibiotice au fost exportate \u015fi pe pie\u0163ele din Europa, Orientul Mijlociu \u015fi Rusia \u2013 \u0163\u0103rile foste C.S.I.<\/p>\n<p style=\"text-align: justify;\">Principalele produse finite exportate de c\u0103tre Antibiotice au fost din clasa antiinfec\u0163ioase, pentru care compania este recunoscut\u0103 at\u00e2t pe plan na\u0163ional c\u00e2t \u015fi la nivel mondial. De asemenea, s-au \u00eenregistrat cre\u015fteri \u00een v\u00e2nz\u0103rile de medicamente din clasele cardiovascular, preparate dermatologice \u015fi tract digestiv.<\/p>\n<p style=\"text-align: justify;\">Strategia de cre\u015ftere pe pie\u0163ele interna\u0163ionale vizeaz\u0103 promovarea produselor at\u00e2t pe segmentul de pia\u0163\u0103 de retail (v\u00e2nz\u0103ri \u00een \u00a0farmacii) c\u00e2t \u015fi v\u00e2nz\u0103ri pe segmentul hospital.<\/p>\n<p style=\"text-align: justify;\">\n","protected":false},"excerpt":{"rendered":"<p>Ast\u0103zi, 15 februarie 2016, compania Antibiotice SA (simbol ATB) a remis Bursei de Valori Bucure\u015fti&#8230; <a class=\"meta-more\" href=\"http:\/\/infois.ro\/?p=21945\">more <span class=\"meta-nav\">&raquo;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":14461,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6,41],"tags":[74,279,1553,635,40,3123,1833],"aioseo_notices":[],"_links":{"self":[{"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/posts\/21945"}],"collection":[{"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/infois.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=21945"}],"version-history":[{"count":1,"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/posts\/21945\/revisions"}],"predecessor-version":[{"id":21946,"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/posts\/21945\/revisions\/21946"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/media\/14461"}],"wp:attachment":[{"href":"http:\/\/infois.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=21945"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/infois.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=21945"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/infois.ro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=21945"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}